La publicación evalúa en forma cuantitativa y cualitativa el costo socioeconómico de la tuberculosis en el Perú con la finalidad de mejorar la comprensión real de gasto social y costo que representa para las personas, familias y Estado peruano. Asimismo, desarrolla bajo el marco del Objetivo 4 ...del programa “Haciendo la diferencia: Consolidando una respuesta integral contra la tuberculosis en el Perú.
more
Revised National Tuberculosis Control Programme
This revision covers the main non-communicable diseases in Mozambique as well as the National Strategic Plan's aim to create a positive environment to minimize or eliminate the exposure to risk factors and guarantee access to care.
Q4: Should community based rehabilitation be offered to children with intellectual disabilities?
A Technical Paper. Final Report
Anti-stigma programs have exploded in the United States as well as across
the world in the past decade. Now needed is a more strategic approach to stigma
change, consideration of evaluation strategies that demonstrate its effectiveness.
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q8: For people with dementia, what is the role of a medical review (including comorbid physical and mental conditions and medication use)?
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
Ghana Med J. 2012 Jun;46(2 Suppl):69-78.
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio...ns (NGOs), donors and TB advocates.
This guide does not replace other guidelines and documents that contain important medical information, such as Guidelines for the Programmatic Management of Drug-resistant TB (WHO, 2008 and 2011 updates), and Management of MDR-TB: A Field Guide (WHO, 2009).
more
SAJCC July 2011, Vol. 27, No. 1